The therapeutic concept of "patient management" in atopic eczema

Allergy: European Journal of Allergy and Clinical Immunology

Volumn 51, Issue 4, 1996, Pages 206-215

  Ring, J ^a   Brockow, K ^a   Abeck, D ^a  

^a TECHNICAL UNIVERSITY OF MUNICH   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON; METHYLPREDNISOLONE ACEPONATE; MOMETASONE FUROATE; PREDNICARBATE; UREA;

ATOPIC DERMATITIS; CORTICOSTEROID THERAPY; DOCTOR PATIENT RELATION; DRUG THERAPY; ENVIRONMENTAL FACTOR; HERBAL MEDICINE; HUMAN; PHOTOTHERAPY; PRIORITY JOURNAL; REVIEW; RISK FACTOR; TOPICAL DRUG ADMINISTRATION; TREATMENT PLANNING;

CASE MANAGEMENT; DERMATITIS, ATOPIC; HUMANS;

EID: 0030011168     PISSN: 01054538     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1398-9995.1996.tb04595.x     Document Type: Review

References (116)

1. Ruzicka T, Ring J, Przybilla B, editors. Handbook of atopic eczema. Berlin: Springer, 1991.
2. Ring J. Atopy: condition, disease, or syndrome? In: Ruzicka T, Ring J, Przybilla B, editors. Handbook of atopic eczema. Berlin: Springer, 1991:3-8.
3. Ring J, Schäfer T. Epidemiologie allergischer Erkrankungen. Dtsch Derm 1995;43:142-6.
4. Schultz Larsen F, Holm NV, Henningsen K. Atopic dermatitis. A genetic-epidemiologic study in a population-based twin sample. J Am Acad Dermatol 1986;15:487-94.
5. Schultz Larsen F. A genetic-epidemiologic study in a population-based twin sample. J Am Acad Dermatol 1993;28:719-23.
6. Guillet GG, Guillet MH. Natural history of sensitizations in atopic dermatitis. Arch Dermatol 1992;128:187-92.
7. Musgrove K, Morgan J. Infantile eczema. A long-term follow-up study. Br J Dermatol 1976;95:365-72.
8. Lapidus CS, Schwarz DF, Honig PJ. Atopic dermatitis in children: who cares? who pays? J Am Acad Dermatol 1993;28:699-703.
9. Bos JD, Kapsenberg M, Smitt JH. Pathogenesis of atopic eczema. Lancet 1994;343:1338-41.
10. Cooper KD. Atopic dermatitis: recent trends in pathogenesis and therapy. J Invest Dermatol 1994;102:128-37.
11. Shuster S, Fisher GH, Harris E, Binnel D. The effect of skin disease on self-image. Br J Dermatol 1978;99 Suppl 16:18-19.
12. Przybilla B, Eberlein-König B, Rueff F. Practical management of atopic eczema. Lancet 1994;343:1342-6.
13. Broberg A, Kalimo K, Lindblad B, Swanbeck B. Parental education in the treatment of childhood atopic eczema. Acta Derm Venereol (Stockh) 1990;70:495-9.
14. Sampson HA. The immunopathogenic role of food hypersensitivity in atopic dermatitis. Acta Derm Venereol Suppl (Stockh) 1992;176:34-7.
15. Hanifin JM, Raika G. Diagnostic features of atopic dermatitis. Acta Derm Venereol Suppl (Stockh) 1980;92:44-7.
16. Przybilla B. Stigmata of atopic condition. In: Ruzicka T, Ring J, Przybilla B, editors. Handbook of atopic eczema. Berlin: Springer, 1991:31-45.
17. Ring J, Dorsch W. Altered releasability of vasoactive mediator secreting cells in atopic eczema. Acta Derm Venereol (Stockh) 1985;114:9-23.
18. Morren MA, Przybilla B, Bamelis M, Heykants B, Reynaers A, Degreef H. Atopic dermatitis: triggering factors. J Am Acad Dermatol 1994;31:467-73.
19. Dahl MV. Antimicrobial agents in the treatment of atopic eczema. In: Ruzicka T, Ring J, Przybilla B, editors. Handbook of atopic eczema. Berlin: Springer, 1991:391-5.
20. Ring J, Abeck D, Neuber K. Atopic eczema: role of microorganisms on the skin surface. Allergy 1992;47:265-9.
21. Gollhausen R. The phenomenon of irritable skin in atopic eczema. In: Ruzicka T, Ring J, Przybilla B, editors. Handbook of atopic eczema. Berlin: Springer, 1991:306-18.
22. Nassif A, Chan SC, Storrs FJ, Hanifin JM. Abnormal skin irritancy in atopic dermatitis and in atopy without dermatitis. Arch Dermatol 1994;130:1402-7.
23. Piérard GE. What do you mean by dry skin? Dermatologica 1989;179:1-2.
24. Imokawa G, Abe A, Jin K, Higaki Y, Kawashima M, Hidano A. Decreased level of ceramides in stratum corneum of atopic dermatitis: an etiological factor in atopic dry skin? J Invest Dermatol 1991;96:523-6.
25. Werner Y, Lindberg M. Transepidermal water loss in dry and clinically normal skin in patients with atopic dermatitis. Acta Derm Venereol (Stockh) 1985;65:102-5.
26. Tupker RA, Pinnagoda J, Coenraads PJ, Nater PJ. Susceptibility to irritants: role of barrier function, skin dryness and history of atopic dermatitis. Br J Dermatol 1990;123:199-205.
27. Abeck D, Ruzicka T. Bacteria and atopic eczema: merely association or etiologic factor? In: Ruzicka T, Ring J, Przybilla B, editors. Handbook of atopic eczema. Berlin: Springer, 1991:212-20.
28. Braunstein Wilson B, Deuell B, Platts-Mills TAE. Atopic dermatitis associated with dermatophyte infection and Trichophyton hypersensitivity. Cutis 1993;51:191-2.
29. Buslau M, Menzel I, Holzmann H. Fungal flora of human faeces in psoriasis and atopic dermatitis. Mycoses 1990;33:90-4.
30. Savolainen J, Lammintausta K, Kalimo K, Viander M. Candida albicans and atopic dermatitis. Clin Exp Allergy 1993;23:332-9.
31. Vieluf D, Ruzika T. Complications and diseases associated with atopic eczema. In: Ruzicka T, Ring J, Przybilla B, editors. Handbook of atopic eczema. Berlin: Springer, 1991:54-79.
32. Hünecke P, Bosse K, Finck H. Krankheitsverlauf und psychosoziale Ereignisse während der stationären Behandlung atopischer Ekzematiker - eine Pilotstudie. Z Hautkr 1990;65:428-34.
33. Ginsburg IH, Prystowsky JH, Kornfeld DS, Wolland H. Role of emotional factors in adults with atopic dermatitis. Int J Dermatol 1993;32:656-60.
34. Cotterill JA. Psychosomatic approaches in the treatment of atopic eczema. In: Ruzicka T, Ring J, Przybilla B, editors. Handbook of atopic eczema. Berlin: Springer, 1991:459-65.
35. Stewart AC, Thomas SE. Hypnotherapy as a treatment for atopic dermatitis in adults and children. Br J Dermatol 1995;132:778-83.
36. Keong CH, Kurumaji Y, Miamoto C, Fukuro S, Kondo S, Nishioka K. Photosensitivity in atopic dermatitis: demonstration of abnormal response to UVB. J Dermatol 1992;19:342-7.
37. Steiger T, Borelli S. Significance of climatic factors in the treatment of atopic eczema. In: Ruzicka T, Ring J, Przybilla B, editors. Handbook of atopic eczema. Berlin: Springer, 1991:415-28.
38. Kemmett D, Tidman MJ. The influence of the menstrual cycle and pregnancy on atopic dermatitis. Br J Dermatol 1991;125:59-61.
39. Ring J. Angewandte Allergologie. 2nd ed. München: MMV Medizin, 1988.
40. Tuft LA. Importance of inhalant allergens in atopic dermatitis. J Invest Dermatol 1949;12:211-19.
41. Przybilla B, Ring J. Food allergy and atopic eczema. Semin Dermatol 1990;9:220-5.
42. Ring J, Vieluf D. Adverse reactions to food. In: Vermeer BJ, Wuepper KJ, van Vloten WA, Baart de la Faille H, van der Schroeff JG, editors. Metabolic disorders and nutrition correlated with skin. Curr Probl Dermatol 1991;20:187-202.
43. Lehmann P, Schmidt K, Goerz G. Nahrungsmittelallergie: Hauttestung mit kommerziellen Nahrungsmittelextrakten oder mit Naturprodukten? Z Hautkr 1990;65:365-70.
44. Pastorello E, Stocchi L, Bigi A, et al. Value and limits of diagnostic tests in food hypersensitivity. Allergy 1989;44 Suppl 9:151-8.
45. Fälth-Magnusson K, Kjellman N-IM. Development of atopic disease in babies whose mothers were on exclusion diet during pregnancy - a randomized study. J Allergy Clin Immunol 1987;80:868-75.
46. Lilja G, Dannaeus A, Foucard T, Graff-Lonnevig V, Johansson SGO, Öman H. Effects of maternal diet during late pregnancy and lactation on the development of atopic diseases in infants up to eighteen month of age: in vivo results. Clin Exp Allergy 1989;19:473-9.
47. Arshad SH, Mathews S, Grant C, Hide DW. Effect of allergen avoidance on development of allergic disorders in infancy. Lancet 1992;339:1493-7.
48. Chandra RK, Puri S, Hamed A. Influence of maternal diet during lactation and use of formula feeds on the development of atopic eczema in high risk infants. BMJ 1989;299:228-30.
49. Fergusson DM, Horwood LJ, Shannon FT. Early solid feeding and recurrent childhood eczema: a 10-year longitudinal study. Pediatrics 1990;86:541-6.
50. Kojosaari M, Saarinen UM. Prophylaxis of atopic disease by six months' total solid food elimination. Acta Paediatr Scand 1983;72:411-14.
51. Saarinen UM, Kajosaari M. Does dietary elimination in infancy prevent or postpone food allergy? Lancet 1980;1:166-7.
52. Platts-Mills TAE, Chapman D, Mitchell B, Heymann PW, Deuell B. In: Ruzicka T, Ring J, Przybilla B, editors. Handbook of atopic eczema. Berlin: Springer, 1991:192-203.
53. Clark ADF, Adinoff AD. Aeroallergen contact can exacerbate atopic dermatitis: patch test as a diagnostic tool. J Am Acad Dermatol 1989;21:863-9.
54. Clark RAF, Adinoff AD. The relationship between positive aeroallergen patch test reactions and aeroallergen exacerbations of atopic dermatitis. Clin Immunol Immunopathol 1989;53 Suppl:S132-40.
55. Tanaka M, Aiba S, Matsumura N, et al. IgE-mediated hypersensitivity and contact sensitivity to multiple environmental allergens in atopic dermatitis. Arch Dermatol 1994;130:1393-40.
56. Seidenari S, Manzini BM, Danese P, Gianetti A. Positive patch tests to whole mite culture and purified mite extracts in patients with atopic dermatitis, asthma and rhinitis. Ann Allergy 1992;92:201-6.
57. vanVoorst Vader PC, Lier JG, Woest GE, Caonraads PJ, Nater PJ. Patch test with house dust mite antigens in atopic dermatitis patients: methodological problems. Acta Derm Venereol (Stockh) 1991;71:301-5.
58. Darsow U, Vieluf D, Ring J. Atopy patch test with different vehicles and allergen concentrations: an approach to standardisation. J Allergy Clin Immunol 1995;95:677-84.
59. Kapsenberg ML, Wierenga EA, Bos JD, Jansen HM. Functional subsets of allergen-reactive human T cell clones. J Immunol 1990;147:2942-9.
60. Colloff MJ. Exposure to house dust mites in homes of people with atopic dermatitis. Br J Dermatol 1992; 127:322-7.
61. Kubota Y, Imayama S, Hori Y. Reduction of environmental mites improved atopic dermatitis patients with positive mite-patch tests. J Dermatol 1992;19:177-80.
62. Sanda T, Yasue T, Oohashi M, Yasue A. Effectiveness of house dust-mite allergen avoidance through clean room therapy in patients with atopic dermatitis. J Allergy Clin Immunol 1992;89:653-7.
63. Leroy BP, Boden G, Lachapelle JM, Jaquemin MG, Saint-Remy JMR. A novel therapy for atopic dermatitis with antigen-allergen complexes: a double blind, placebo-controlled study. J Am Acad Dermatol 1993;28:232-9.
64. Rasanen L, Reunala T, Lehto M, Virtanen E, Arvilommi H. Immediate and delayed hypersensitivity reactions to birch pollen in patients with atopic dermatitis. Acta Derm Venereol (Stockh) 1992;72:193-6.
65. Reitamo S, Visa K, Kahonen K, Kayhko K, Stubb S, Salo OP. Eczematous reactions in atopic patients caused by epicutaneous testing with inhalant allergens. Br J Dermatol 114:303.
66. Dooms-Goossens A, Morren M. Results of routine patch testing with corticosteroid series in 2073 patients. Contact Dermatitis 1992;26:182-91.
67. Niedner R, Schöpf E. Clinical efficacy of topical glucocorticoid preparations and other types of dermatics in inflammatory diseases, particularly in atopic dermatitis. In: Burg G, editor. Curr Probl Dermatol 1993;21:157-69.
68. Coopman S, Dooms-Goossens A. Cross-reactions in topical corticosteroid contact dermatitis. Contact Dermatitis 1988;19:145-6.
69. Wilkinson SM, Hollis S, Beck MH. Reactions to other corticosteroids in patients with allergic contact dermatitis from hydrocortisone. Br J Dermatol 1995:132:766-71.
70. Schöpf E, Mueller JM, Ostermann T, Stellenwert der adjuvanten Basistherapie bei chronisch-rezidivierenden Hauterkrankungen. Hautarzt 1995;44:451-4.
71. Braun-Falco O, Plewig G, Wolff HH, editor. Dermatologie und Venerologie. Berlin: Springer, 1985:979-1017.
72. Korting HC. Dermatotherapie. Berlin: Springer, 1995.
73. Wohlrab W. Neurodermitis und Harnstoff. Hautarzt 1992;(Suppl 11):1-4.
74. Wohlrab W. Vehikelabhängigkeit der Harnstoffpenetration in der menschlichen Haut Dermatologica 1984;169:53-9.
75. Gabard B, Bieli E. Measurement of lipid deposition on the skin of the forearm: comparison of different bath oils. J Soc Cosmet Chem 1991;42:299-308.
76. Gloor M. Körperpflege bei Neurodermits. TW Dermatologie 1991;21:341-8.
77. Gloor M. Wenig waschen und viel cremen! Therapiewoche 1992;42:1410-16.
78. White MI, Batten TL, Ormerod AD. Adverse effects of a daily bathing routine on children with atopic dermatitis. J Dermatol Treatment 1994;5:21-4.
79. 4) on bacterial skin flora in atopic dermatitis. Acta Derm Venereol (Stockh) 1992;176 Suppl:132-4.
80. David JJ, Cambridge JC. Bacterial infection and atopic eczema. Arch Dis Childhood 1986;61:20-3.
81. Clemmensen O, Hjorth N. Treatment of dermatitis of the head and neck with ketoconazole in patients with type I sensitivity to Pityrosporum orbiculare. Semin Dermatol 1983;2:26-9.
82. Broberg A, Faergemann J. Topical antimycotic treatment of atopic dermatitis in the head neck area. Acta Derm Venercol (Stockh) 1995;75:46-9.
83. Hornstein OP. Guidelines for topical treatment in atopic eczma. In: Ruzicka T, Ring J, Przybilla B, editors. Handbook of atopic eczema. Berlin: Springer, 1991:345-55.
84. Ippen H, Grimmer G. Carcinogenic hydrocarbons in therapeutic "tars". Z Hautkr 1993;68:88-92.
85. Korting HC, Vieluf D, Kerscher M. 0.25% Prednicarbat cream and the corresponding vehicle induce less skin atrophy than 0.1% betamethasone-17-valerate cream and 0.05% clobetasol-17-propionate cream. Eur J Clin Pharmacol 1992;42:159-61.
86. Brasch J. The atrophogenic potential of mometasone furoate in a clinical long-term study. Z Hautkr 1991;66:785-7.
87. Ortonne JP. Safety aspects of topical methylprednisolone acepnate (MPA) treatment. J Dermatol Treatment 1992;3 Suppl 2:21-5.
88. Korting HC, Zienicke H, Braun-Falco O, et al. Modern topical glucocorticoids and anti-infectives for superinfected atopic eczema: do prednicarbate and didecyldimetyl-ammonium chloride form a rational combination? Infection 1994;22:390-4.
89. Goodyear M, Spowart K, Harper JI. "Wet-wrap" dressings for the treatment of atopic eczema in children. Br J Dermatol 1991;125:604.
90. Mallon E, Powell S, Bridgman A. "Wet-wrap" dressings for the treatment of atopic eczema in the community. J Dermatol Treatment 1994;5:97-8.
91. Simons FER, Simons KJ, Becker AB, Haydey RP. Pharmacokinetics and antipruritic effects of hydroxyzine in children with atopic dermatitis. J Pediatr 1984;104:123-7.
92. Hanifin JM. Atopic dermatitis: new therapeutic considerations. J Am Acad Dermatol 1991;24:1097-1101.
93. Abeck D, Korting HC. Einsatz von Antibiotika bei Hauterkrankungen. Bayer Internist 1991;11:45-53.
94. Jekler J. Phototherapy of atopic dermatitis with ultraviolet radiation. Acta Derm Venereol (Stockh) 1992; Suppl 171:1-37.
95. Lacoste-Caillet P, Loesche C, Thomas P. Phototherapy of atopic dermatitis: selective UV phototherapy (SUP) versus UVA-UVB. Nouv Dermatol 1992;11:353-6.
96. Morrison WL, Parrish JA, Fitzpatrick TB. Oral psoralen photochemotherapy of atopic eczema. Br J Dermatol 1978;98:25-30.
97. Sheehan MP, Atherton DJ, Norris P, Hawk J. Oral psoralen photochemotherapy in severe childhood atopic eczema: an update. Br J Dermatol 1993;129:431-6.
98. Krutmann J, Czech W, Diepgen T, Niedner R, Kapp A, Schöpf E. High-dose UVA1 therapy in the treatment of patients with atopic dermatitis. J Am Acad Dermatol 1992;26:225-30.
99. Kowalzick L, Kleinheinz A, Weichenthal M, et al. Low dose versus medium dose UV-A1 treatment in severe atopic eczema. Acta Derm Venereol (Stockh) 1995;75:43-5.
100. Berth-Jones J, Graham-Bron RAC. Placebo-controlled trial of essential fatty acid supplementation in atopic dermatitis. Lancet 1993;341:1557-60.
101. Morse PF, Horrobin DF, Manku MS, et al. Meta-analysis of placebo-controlled studies of efficacy of Epogam in the treatment of atopic eczema. Relationship between plasma essential fatty acid changes and clinical response. Br J Dermatol 1989;121:75-90.
102. Reinhold U, Kukel S, Brzoska J, Kreysel H. Systemic interferon gamma treatment in severe atopic dermatitis. J Am Acad Dermatol 1993;29:58-63.
103. Hanifin JM, Schneider L, Leung D, et al. Recombinant interferon gamma therapy for atopic dermatitis. J Am Acad Dermatol 1993;28:189-97.
104. Torrelo A, Harto A, Sendagorta E, Czarnetzki BM, Ledop A. Interferon-α therapy in atopic dermatitis. Acta Derm Venereol (Stockh) 1992;72:370-2.
105. Sowden JM, Berth-Jones, Ross JS, et al. A multicentre, double-blind, placebo-controlled crossover study to assess the efficacy and safety of cyclosporin in adult patients with severe atopic dermatitis. Lancet 1991;338:137-40.
106. Wahlgren CF, Scheynius A, Hägermark Ö. Antipruritic effect of oral cyclosporine A in atopic dermatitis. Acta Derm Venereol (Stockh) 1990;70:323-9.
107. Granlund H, Erkko P, Sinisalo M, Reitamo S. Cyclosporin in atopic dermatitis: time to relapse and effect of intermittent therapy. Br J Dermatol 1995;132:106-12.
108. Nakagawa H, Etoh T, Ishibashi Y, et al. Tacrolismus ointment for atopic dermatitis. Lancet 1994;334:883.
109. Sheehan MP, Atherton DJ. One-year follow-up of children treated with Chinese medical herbs for atopic eczema. Br J Dermatol 1994;130:488-93.
110. Sheehan MP, Rustin MHA, Atherton DJ, et al. Efficacy of traditional Chinese herbal therapy in adult atopic dermatitis. Lancet 1992;340:13-17.
111. Mostefa-Kara N, Pauwels A, Pinus E, Biour M, Levy VG. Fatal hepatitis after herbal tea. Lancet 1992;340:674.
112. Perharic-Walton L, Murray V. Toxicity of Chinese herbal remedies. Lancet 1992;340:673.
113. Harper J. Traditional Chinese medicine for eczema. BMJ 1995;308:489-90.
114. Hsieh KH, Shaio MF, Liao TN. Thymopentin treatment in severe atopic dermatitis: clinical and immunological evaluations. Arch Dis Child 1992;67:1095-1102.
115. Prinz B, Nachbar T, Plewig G. Treatment of severe atopic dermatitis with extracorporeal photophoresis. Arch Dermatol Res 1994;287:48-52.
116. 2 fragments of specific antibodies. Br J Dermatol 1995;132:599-603.